Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells

Cell Reports

Volumn 8, Issue 6, 2014, Pages 1905-1918

  Ting, David T ^a   Wittner, Ben S ^a   Ligorio, Matteo ^a,b   Vincent Jordan, Nicole ^a   Shah, Ajay M ^a   Miyamoto, David T ^a   Aceto, Nicola ^a   Bersani, Francesca ^a   Brannigan, Brian W ^a   Xega, Kristina ^a   Ciciliano, Jordan C ^a   Zhu, Huili ^a   MacKenzie, Olivia C ^a   Trautwein, Julie ^a   Arora, Kshitij S ^a   Shahid, Mohammad ^a   Ellis, Haley L ^a   Qu, Na ^a   Bardeesy, Nabeel ^a   Rivera, Miguel N ^a   Deshpande, Vikram ^a   Ferrone, Cristina R ^a   Kapur, Ravi ^a   Ramaswamy, Sridhar ^a   Shioda, Toshi ^a   Toner, Mehmet ^a   Maheswaran, Shyamala ^a   Haber, Daniel A ^a,c   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEONECTIN; SHORT HAIRPIN RNA; TRANSCRIPTOME; ALDH1A2 PROTEIN, HUMAN; CARRIER PROTEIN; IGFBP5-INTERACTING PROTEIN, HUMAN; RETINAL DEHYDROGENASE; SMALL INTERFERING RNA;

ALDH1A2 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; EMBRYO; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LGFBP5 GENE; LUNG METASTASIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; MICROFLUIDIC ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; RNA SEQUENCE; SINGLE CELL RNA SEQUENCING; STROMA; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; RNA INTERFERENCE; SEQUENCE ANALYSIS; TUMOR CELL CULTURE; TUMOR EMBOLISM;

ANIMALS; CARRIER PROTEINS; CELL MOVEMENT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASTIC CELLS, CIRCULATING; OSTEONECTIN; PANCREATIC NEOPLASMS; RETINAL DEHYDROGENASE; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, RNA; TUMOR CELLS, CULTURED;

EID: 84907414338     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.08.029     Document Type: Article

References (49)

1. Adany R., Heimer R., Caterson B., Sorrell J.M., Iozzo R.V. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J. Biol. Chem. 1990, 265:11389-11396.
2. Bardeesy N., Aguirre A.J., Chu G.C., Cheng K.H., Lopez L.V., Hezel A.F., Feng B., Brennan C., Weissleder R., Mahmood U., et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc. Natl. Acad. Sci. USA 2006, 103:5947-5952.
3. Boström P., Sainio A., Kakko T., Savontaus M., Söderström M., Järveläinen H. Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast. Histochem. Cell Biol. 2013, 139:161-171.
4. Breitling R., Armengaud P., Amtmann A., Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 2004, 573:83-92.
5. Brembeck F.H., Rustgi A.K. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. J. Biol. Chem. 2000, 275:28230-28239.
6. Cann G.M., Gulzar Z.G., Cooper S., Li R., Luo S., Tat M., Stuart S., Schroth G., Srinivas S., Ronaghi M., et al. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS ONE 2012, 7:e49144.
7. Carvalho F.L., Simons B.W., Antonarakis E.S., Rasheed Z., Douglas N., Villegas D., Matsui W., Berman D.M. Tumorigenic potential of circulating prostate tumor cells. Oncotarget 2013, 4:413-421.
8. Feig C., Gopinathan A., Neesse A., Chan D.S., Cook N., Tuveson D.A. The pancreas cancer microenvironment. Clin. Cancer Res. 2012, 18:4266-4276.
9. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
10. Hao X., Sun B., Hu L., Lähdesmäki H., Dunmire V., Feng Y., Zhang S.W., Wang H., Wu C., Wang H., et al. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 2004, 100:1110-1122.
11. Henke A., Grace O.C., Ashley G.R., Stewart G.D., Riddick A.C., Yeun H., O'Donnell M., Anderson R.A., Thomson A.A. Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer. PLoS ONE 2012, 7:e42516.
12. Hunzelmann N., Schönherr E., Bonnekoh B., Hartmann C., Kresse H., Krieg T. Altered immunohistochemical expression of small proteoglycans in the tumor tissue and stroma of basal cell carcinoma. J. Invest. Dermatol. 1995, 104:509-513.
13. Infante J.R., Matsubayashi H., Sato N., Tonascia J., Klein A.P., Riall T.A., Yeo C., Iacobuzio-Donahue C., Goggins M. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. J. Clin. Oncol. 2007, 25:319-325.
14. Iozzo R.V., Cohen I. Altered proteoglycan gene expression and the tumor stroma. EXS 1994, 70:199-214.
15. Johnson S.K., Haun R.S. Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth. World J. Gastroenterol. 2009, 15:3355-3366.
16. Johnson S.K., Dennis R.A., Barone G.W., Lamps L.W., Haun R.S. Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray. Mol. Carcinog. 2006, 45:814-827.
17. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
18. Krause D.S., Ito T., Fackler M.J., Smith O.M., Collector M.I., Sharkis S.J., May W.S. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 1994, 84:691-701.
19. Labelle M., Begum S., Hynes R.O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011, 20:576-590.
20. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massagué J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
21. Mu Y., Chen Y., Zhang G., Zhan X., Li Y., Liu T., Li G., Li M., Xiao Z., Gong X., Chen Z. Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics. Electrophoresis 2013, 34:1679-1692.
22. Muzumdar M.D., Tasic B., Miyamichi K., Li L., Luo L. A global double-fluorescent Cre reporter mouse. Genesis 2007, 45:593-605.
23. Naba A., Clauser K.R., Hoersch S., Liu H., Carr S.A., Hynes R.O. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics 2012, 11. M111 014647.
24. Nash M.A., Deavers M.T., Freedman R.S. The expression of decorin in human ovarian tumors. Clin. Cancer Res. 2002, 8:1754-1760.
25. Neesse A., Michl P., Frese K.K., Feig C., Cook N., Jacobetz M.A., Lolkema M.P., Buchholz M., Olive K.P., Gress T.M., Tuveson D.A. Stromal biology and therapy in pancreatic cancer. Gut 2011, 60:861-868.
26. Neesse A., Frese K.K., Bapiro T.E., Nakagawa T., Sternlicht M.D., Seeley T.W., Pilarsky C., Jodrell D.I., Spong S.M., Tuveson D.A. CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer. Proc. Natl. Acad. Sci. USA 2013, 110:12325-12330.
27. Neesse A., Frese K.K., Chan D.S., Bapiro T.E., Howat W.J., Richards F.M., Ellenrieder V., Jodrell D.I., Tuveson D.A. SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice. Gut 2014, 63:974-983.
28. Neuzillet C., Tijeras-Raballand A., Cros J., Faivre S., Hammel P., Raymond E. Stromal expression of SPARC in pancreatic adenocarcinoma. Cancer Metastasis Rev. 2013, 32:585-602.
29. Olive K.P., Jacobetz M.A., Davidson C.J., Gopinathan A., McIntyre D., Honess D., Madhu B., Goldgraben M.A., Caldwell M.E., Allard D., et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461.
30. Ozkumur E., Shah A.M., Ciciliano J.C., Emmink B.L., Miyamoto D.T., Brachtel E., Yu M., Chen P.I., Morgan B., Trautwein J., et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med 2013, 5:179ra147.
31. Pantel K., Brakenhoff R.H., Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 2008, 8:329-340.
32. Prasad N.B., Biankin A.V., Fukushima N., Maitra A., Dhara S., Elkahloun A.G., Hruban R.H., Goggins M., Leach S.D. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res. 2005, 65:1619-1626.
33. Provenzano P.P., Cuevas C., Chang A.E., Goel V.K., Von Hoff D.D., Hingorani S.R. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 2012, 21:418-429.
34. Ramsköld D., Luo S., Wang Y.C., Li R., Deng Q., Faridani O.R., Daniels G.A., Khrebtukova I., Loring J.F., Laurent L.C., et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat. Biotechnol. 2012, 30:777-782.
35. Rasheed Z.A., Matsui W. Biological and clinical relevance of stem cells in pancreatic adenocarcinoma. J. Gastroenterol. Hepatol. 2012, 27(Suppl 2):15-18.
36. Rasheed Z.A., Yang J., Wang Q., Kowalski J., Freed I., Murter C., Hong S.M., Koorstra J.B., Rajeshkumar N.V., He X., et al. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J. Natl. Cancer Inst. 2010, 102:340-351.
37. Rasheed Z.A., Matsui W., Maitra A. Pathology of pancreatic stroma in PDAC. Pancreatic Cancer and Tumor Microenvironment 2012, Trivandrum, India. P.J. Grippo, H.G. Munshi (Eds.).
38. Rhim A.D., Mirek E.T., Aiello N.M., Maitra A., Bailey J.M., McAllister F., Reichert M., Beatty G.L., Rustgi A.K., Vonderheide R.H., et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148:349-361.
39. Sato N., Fukushima N., Maehara N., Matsubayashi H., Koopmann J., Su G.H., Hruban R.H., Goggins M. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene 2003, 22:5021-5030.
40. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
41. Tang F., Barbacioru C., Nordman E., Li B., Xu N., Bashkirov V.I., Lao K., Surani M.A. RNA-Seq analysis to capture the transcriptome landscape of a single cell. Nat. Protoc. 2010, 5:516-535.
42. Wei D., Wang L., Kanai M., Jia Z., Le X., Li Q., Wang H., Xie K. KLF4α up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology 2010, 139:2135-2145.
43. Weigelt B., Wessels L.F., Bosma A.J., Glas A.M., Nuyten D.S., He Y.D., Dai H., Peterse J.L., van't Veer L.J. No common denominator for breast cancer lymph node metastasis. Br. J. Cancer 2005, 93:924-932.
44. Whitfield M.L., Sherlock G., Saldanha A.J., Murray J.I., Ball C.A., Alexander K.E., Matese J.C., Perou C.M., Hurt M.M., Brown P.O., Botstein D. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 2002, 13:1977-2000.
45. Wong S.Y., Crowley D., Bronson R.T., Hynes R.O. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer. Clin. Exp. Metastasis 2008, 25:109-118.
46. Yu M., Stott S., Toner M., Maheswaran S., Haber D.A. Circulating tumor cells: approaches to isolation and characterization. J. Cell Biol. 2011, 192:373-382.
47. Yu M., Ting D.T., Stott S.L., Wittner B.S., Ozsolak F., Paul S., Ciciliano J.C., Smas M.E., Winokur D., Gilman A.J., et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 2012, 487:510-513.
48. Yu M., Bardia A., Wittner B.S., Stott S.L., Smas M.E., Ting D.T., Isakoff S.J., Ciciliano J.C., Wells M.N., Shah A.M., et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013, 339:580-584.
49. Zhang X.H., Jin X., Malladi S., Zou Y., Wen Y.H., Brogi E., Smid M., Foekens J.A., Massagué J. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell 2013, 154:1060-1073.